Exact Sciences Launches Cancerguard
Exact Sciences announced recently the launch of Cancerguard, a multi-cancer early detection (MCED) blood test that is now available as a laboratory-developed test (LDT) in the United States. According to…
Category Archives: Biotech
Promega, Watchmaker Genomics to Partner
Promega has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase, the company announced today. According to a release, the enzyme will enhance Promega’s capabilities…
Imbed Biosciences Adds PainGuard Products
Imbed Biosciences recently announced the launch of SAM PainGuard with Lidocaine, which encompasses Surgaflex PainGuard for surgical wounds and Pelashield PainGuard for burn and trauma wound management. “Nearly 90% of…
Exact Sciences, Freenome Enter Agreement
Exact Sciences has entered into an exclusive agreement with Freenome, a biotechnology company pioneering an early cancer detection platform, the company announced recently. According to a release, Exact Sciences will…
Promega Commits to SBTi
Promega has committed to set near-term company-wide emission reductions with the Science Based Targets initiative (SBTi), the company announced recently. According to a release, this commitment begins a defined process…
Promega, Longhorn Vaccines and Diagnostics to Partner
Promega and Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, are partnering, the companies recently announced. According to…
Promega, Addgene to Partner
Promega and Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, have partnered, the companies recently announced. According to a release, the partnership will expand…
Exact Sciences Earns Medicare Coverage for Oncodetect Test
Exact Sciences‘ Oncodetect molecular residual disease (MRD) test has received Medicare coverage through the Centers for Medicare & Medicaid Services (CMS) Molecular Diagnostic Services Program (MolDX), the company announced recently….
SHINE, Standard Nuclear to Partner
SHINE Technologies has entered into a strategic partnership with Standard Nuclear, a reactor-agnostic producer of TRISO nuclear fuel and radioisotope power systems, SHINE announced today. According to a release, the…
Voximetry, Medpace Announce Partnership
Voximetry and Medpace Core Laboratories, a full-service core laboratory, have entered a strategic partnership aimed at enhancing radiopharmaceutical clinical trials through the integration of cutting-edge dosimetry technology and comprehensive contract…
